Neurodegeneration – News and Features

The summer issue of Stanford Medicine magazine explores clinical trials in a special report, “Trials on trial: Clinical studies under the microscope.”

A drug-like molecule can be substituted for the cancer gene c-Myc, one of four genes added to adult cells to reprogram them to an embryonic-stem-cell-like state, says Whitehead researchers.

California venture will use personalized stem cell technology to battle disease.

Researchers find that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer.

New key to understanding and treating ALS, and a step toward personalized regenerative medicine.

A new drug has been shown to improve the brain function of Alzheimer's patients and reduce a key protein associated with the disease in the spinal fluid.

Safety and efficacy results presented at International Conference on Alzheimer’s Disease support design of ongoing global Phase 3 program.

Bi-coastal collaboration aimed at applying stem cell technology to an 'orphan disease' in a unique translational research setting.

Zenobia has initiated research at its facility in La Jolla, California using its early-stage drug discovery method of fragment-based lead discovery.

Grant to identify and analyze nanomedicine prototypes for treating allergies and other inflammatory diseases.